The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tanashyan M.M.

Research Center of Neurology

Malyavin A.G.

Russian University of Medicine (Evdokimov Moscow State University of Medicine and Dentistry)

Antonova K.V.

Scientific Center of Neurology»

Maksimova M.Y.

Research Center of Neurology

Raskurazhev A.A.

Research Center of Neurology

Lagoda O.V.

Research Center of Neurology

Kuznetsova P.I.

Research Center of Neurology

Cerebrovascular disease in clinical practice. Resolution of the Expert Council of the Russian Scientific Medical Society of Therapists

Authors:

Tanashyan M.M., Malyavin A.G., Antonova K.V., Maksimova M.Y., Raskurazhev A.A., Lagoda O.V., Kuznetsova P.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(6): 105‑111

DOI: 10.17116/jnevro2025125061105

Read: 1143 times

Buy for 300₽
Contact the author
Table of contents

CEREBROVASCULAR DISEASE IN CLINICAL PRACTICE. RESOLUTION OF THE EXPERT COUNCIL OF THE RUSSIAN SCIENTIFIC MEDICAL SOCIETY OF THERAPISTS
CEREBROVASCULAR DISEASE IN CLINICAL PRACTICE. RESOLUTION OF THE EXPERT COUNCIL OF THE RUSSIAN SCIENTIFIC MEDICAL SOCIETY OF THERAPISTS

To cite this article:

Tanashyan MM, Malyavin AG, Antonova KV, Maksimova MY, Raskurazhev AA, Lagoda OV, Kuznetsova PI. Cerebrovascular disease in clinical practice. Resolution of the Expert Council of the Russian Scientific Medical Society of Therapists. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(6):105‑111. (In Russ.)
https://doi.org/10.17116/jnevro2025125061105

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
Comparative study of cognitive impairment in subgroups of bipo­lar affe­ctive diso­rder types I and II, occu­rring with and without psychotic symptoms. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):7-11
Cognitive functions asse­ssment of elde­rly patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):46-50
Rela­tionship between stroke-associated pneumonia and long-term outcomes of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):57-61
Pote­ntial of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Study of the levo­carnitine effi­cacy for the treatment of mode­rate cognitive impairment in patients with hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(4):45-50
Abstract:

This article highlights the main provisions of the Expert Council on Disorders of Cerebral Circulation and cerebrovascular pathology in clinical practice. As part of the interdisciplinary cooperation program, on December 16, 2024, a Council of Experts in the field of neurology, cardiology and therapy was held at the site of the First Medical Channel in Moscow with the support of the All-Russian Public Organization Russian Scientific Medical Society of Therapists: «Cerebral circulatory disorders and cerebrovascular pathology in clinical practice».

Keywords:

cerebrometabolic health
cerebral circulation disorders
cognitive impairments
diabetes mellitus
myeloproliferative diseases
treatment adherence

Authors:

Tanashyan M.M.

Research Center of Neurology

Malyavin A.G.

Russian University of Medicine (Evdokimov Moscow State University of Medicine and Dentistry)

Antonova K.V.

Scientific Center of Neurology»

Maksimova M.Y.

Research Center of Neurology

Raskurazhev A.A.

Research Center of Neurology

Lagoda O.V.

Research Center of Neurology

Kuznetsova P.I.

Research Center of Neurology

Received:

22.04.2025

Accepted:

24.04.2025

Close metadata

References:

  1. GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10):973-1003. https://doi.org/10.1016/S1474-4422(24)00369-7
  2. World Population Prospects 2022. Summary of results. United Nations Department of Economic and Social Affairs. URL: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/wpp2022_summary_of_results.pdf
  3. Tanashyan MM, Antonova KV. Cerebrometabolic health. In: Ametov AS, et al. Metabolic health management. M. 2025. (In Russ.).
  4. Hayden MR. Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease. Medicina. 2023;59:561.  https://doi.org/10.20944/preprints202302.0115.v1
  5. GBD 2021 Diabetes Collaborators Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203-234.  https://doi.org/10.1016/S0140-6736(23)01301-6
  6. Rinella ME, Lazarus JV, Ratziu VA. Multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542-1556. https://doi.org/10.1016/j.jhep.2023.06.003
  7. Marini S, Merino J, Montgomery B.E, et al. International Stroke Genetics Consortium. Mendelian Randomization Study of Obesity and Cerebrovascular Disease. Ann Neurol. 2020;87(4):516-524.  https://doi.org/10.1002/ana.25686
  8. Letra L, Sena C. Cerebrovascular Disease: Consequences of Obesity-Induced Endothelial Dysfunction. Adv Neurobiol. 2017;19:163-189.  https://doi.org/10.1007/978-3-319-63260-5_7
  9. Horn JW, Feng T, Mørkedal B, et al. Obesity and Risk for First Ischemic Stroke Depends on Metabolic Syndrome: The HUNT Study. Stroke. 2021;52(11):3555-3561. https://doi.org/10.1161/STROKEAHA.120.033016
  10. Shah RV, Murthy VL, Abbasi SA, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging. 2014;7(12):1221-1235. https://doi.org/10.1016/j.jcmg.2014.07.017
  11. Liu Q, Liao X, Pan Y, et al. The Obesity Paradox: Effect of Body Mass Index and Waist Circumference on Post-Stroke Cognitive Impairment. Diabetes Metab Syndr Obes. 2023;16:2457-2467. https://doi.org/10.2147/DMSO.S420824
  12. Mosenzon O, Cheng AY, Rabinstein AA, et al. Diabetes and stroke: What are the connections? Stroke. 2023;25(1):26-38.  https://doi.org/10.5853/jos.2022.02306
  13. Kaynak N, Kennel V, Rackoll T, et al. Impaired glucose metabolism and the risk of vascular events and mortality after ischemic stroke: A systematic review and meta-analysis. Cardiovasc Diabetol. 2024;23(1):323.  https://doi.org/10.1186/s12933-024-02413-w
  14. Tanashyan MM, Antonova KV, Lagoda OV, et al. Acute stroke and type 2 diabetes. Annals of Clinical and Experimental Neurology. 2014;3(8):4-8. (In Russ.).
  15. Allport LE, Baird TA, Davis SM. Hyperglycaemia and the ischaemic brain: continuous glucose monitoring and implications for therapy. Curr Diabetes Rev. 2008;4(3):245-257.  https://doi.org/10.2174/157339908785294433
  16. Hyvärinen M. Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria. Diabetes Care. 2009;32(2):348-335.  https://doi.org/10.2337/dc08-1411
  17. Krinock MJ, Singhal NS. Diabetes, stroke, and neuroresilience: looking beyond hyperglycemia. Ann N Y Acad Sci. 2021;1495(1):78-98.  https://doi.org/10.1111/nyas.14583
  18. van Sloten TT, Sedaghat S, Carnethon MR, et al. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8(4):325-336.  https://doi.org/10.1016/S2213-8587(19)30405-X
  19. Antonova KV, Tanashyan MM, Shabalina AA, et al. Hemostasis in patients with type 2 diabetes mellitus and obesity in acute and chronic cerebrovascular pathology. Tromboz, Gemostaz i Reologiya. 2020;2(82):60-67. (In Russ.). https://doi.org/10.25555/THR.2020.2.0919
  20. Tanashyan MM, Antonova KV, Lagoda OV, et al. Obesity and prothrombotic state in patients with cerebrovascular diseases. Tromboz, Gemostaz i Reologiya. 2023;3:53-62. (In Russ.). https://doi.org/10.25555/THR.2023.3.1069
  21. https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/ https://www.alzint.org/about/dementia-facts-figures/dementia-statistics/
  22. Jia L, Du Y, Chu L, et al. COAST Group. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661-e671. https://doi.org/10.1016/S2468-2667(20)30185-7
  23. Ip BYM, Ko H, Lam BYK, et al. Current and Future Treatments of Vascular Cognitive Impairment. Stroke. 2024;55(4):822-839.  https://doi.org/10.1161/STROKEAHA.123.044174
  24. Li Z, Jiang YY, Long C, et al. Bridging metabolic syndrome and cognitive dysfunction: role of astrocytes. Front Endocrinol (Lausanne). 2024;15:1393253. https://doi.org/10.3389/fendo.2024.1393253
  25. Ding MY, Xu Y, Wang YZ, et al. Predictors of Cognitive Impairment After Stroke: A Prospective Stroke Cohort Study. J Alzheimers Dis. 2019;71(4):1139-1151. https://doi.org/10.3233/JAD-190382
  26. Kunutsor SK. Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in people with type 2 diabetes. Diabetes Obes Metab. 2024;26(6):2069-2081. https://doi.org/10.1111/dom.15511
  27. Rundek T, Tolea M, Ariko T, et al. Vascular Cognitive Impairment (VCI). Neurotherapeutics. 2022;19(1):68-88.  https://doi.org/10.1007/s13311-021-01170-y
  28. Raskurazhev AA, Kuznetsova PI, Tanashyan MM. Non-pharmacological prevention and correction of cognitive disorders. Annals of Clinical and Experimental Neurology. 2020;14(3):60-65. (In Russ.). https://doi.org/10.25692/ACEN.2020.3.8
  29. Epilepsy: a public health imperative. Summary. Geneva: World Health Organization; 2019 (WHO/MSD/MER/19.2).
  30. Singh G, Sander JW. The global burden of epilepsy report: Implications for low- and middle-income countries. Epilepsy Behav. 2020;105:106949. https://doi.org/10.1016/j.yebeh.2020.106949
  31. Maksimova MYu, Gulevskaya TS. Structural epilepsy: current state of the problem. Russian Neurological Journal. 2024;29(4):5-15. (In Russ.). https://doi.org/10.30629/2658-7947-2024-29-4-5-15
  32. Fisher RS, Cross HJ, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for classification and terminology. Epilepsia. 2017;58:522-530.  https://doi.org/10.1111/epi.13670
  33. Feyissa AM, Hasan TF, Meschia JF. Stroke-related epilepsy. Eur J Neurol. 2019;26(1):18-e3.  https://doi.org/10.1111/ene.13813
  34. Maksimova MY, Brutian AG, Shalimanova EV. Epilepsy as part of paroxysmal disorders after ischaemic stroke. Annals of Clinical and Experimental Neurology. 2020;14(3):11-20. (In Russ.). https://doi.org/10.25692/ACEN.2020.3.2
  35. Holtkamp M, Beghi E, Benninger F, et al. European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy. Eur Stroke J. 2017;2:103-115.  https://doi.org/10.1177/2396987317705536
  36. Pitskhelauri DI, Kudieva ES, Melikyan AG, et al. Surgical treatment of drug-resistant epilepsy following hippocampal sclerosis. Burdenko’s Journal of Neurosurgery. 2021;85(5):31-40. (In Russ.). https://doi.org/10.17116/neiro20218505131
  37. Stakhovskaya LV, Mkhitaryan EA, Tkacheva ON, et al. Efficacy and safety of mexidol across age groups in the acute and early recovery stages of hemispheric ischemic stroke (results of additional sub-analysis of a randomized double blind multicenter placebo-controlled study, in parallel groups trial EPICA). S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(8):49-57. (In Russ.). https://doi.org/10.17116/jnevro202012008249
  38. Tanashyan MM, Lagoda OV, Antonova KV. Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(11):21-26. (In Russ.).
  39. Khalaf KM, Khudhair MS, Ashor AW. Vitamin B12 status and peripheral neuropathy in patients with type 2 diabetes mellitus. J Pak Med Assoc. 2019;69:S40-S44. 
  40. Alvarez M, Sierra OR, Saavedra G, et al. Vitamin B12 deficiency and diabetic neuropathy in patients taking metformin: A cross-sectional study. Endocr Connect. 2019;8:1324-1329. https://doi.org/10.1530/EC-19-0382
  41. Alghamdi A. Structural and Functional Brain Changes Associated with Vitamin B12 Deficiency using Magnetic Resonance Imaging: A systematic review and meta-analysis. Curr Med Imaging. 2023;19(4):312-326.  https://doi.org/10.2174/1573405618666220516113758
  42. Hansen CS, Jensen JS, Ridderstråle M, et al. Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes. J Diabetes Complications. 2017;31(1):202-208.  https://doi.org/10.1016/j.jdiacomp.2016.08.025
  43. Leslie KH, McCowan C, Pell JP. Adherence to cardiovascular medication: a review of systematic reviews. J Pub Health. 2018;(41):e84-e94.  https://doi.org/10.1093/pubmed/fdy088
  44. Nikolaev NA, Skirdenko YuP, Balabanova AA, et al. The Scale of Quantitative Assessment Adherence to Treatment «QAA-25»: Updating of Formulations, Constructive and Factor Validity and a Measure of Consent. Rational Pharmacotherapy in Cardiology. 2021;17(6):845-852. (In Russ.). https://doi.org/10.20996/1819-6446-2021-12-12
  45. Fofanova TV, Ageev FT, Smirnova MD, et al. National Questionnaire of Treatment Compliance: Testing and Application in Outpatient Practice. Systemnye Gipertenzii. 2014;11(2):13-16. (In Russ.).
  46. Tanashyan MM, Antonova KV, Lagoda OV, et al. Adherence to treatment in patients with cerebrovascular disease as a multifactorial problem. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(1):18-27. (In Russ.). https://doi.org/10.14412/2074-2711-2023-1-18-27
  47. Melikyan AL, Subortseva IN, Kovrigina AM, et al. National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024). Clinical oncohematology. 2024;17(3):291-334. (In Russ.). https://doi.org/10.21320/2500-2139-2024-17-3-291-334
  48. Kuznetsova PI, Raskurazhev AA, Melikyan AL, et al. Analysis of risk factors associated with ischemic stroke in the setting of Ph-negative myeloproliferative diseases. Russian Journal of Preventive Medicine. 2025;28(1):50-56. (In Russ.). https://doi.org/10.17116/profmed20252801150
  49. Tanashyan MM, Kuznetsova PI, Raskurazhev AA, et al. Clinical and neuroimaging patterns of ischemic stroke in Ph-negative myeloproliferative neoplasms. Annals of Clinical and Experimental Neurology. 2024;18(3):14-25. (In Russ.). https://doi.org/10.17816/ACEN.1164
  50. Kuznetsova PI, Melikyan AL, Subortseva IN, et al. Prerevention of ischemic stroke in patients with myeloproliferative neoplasms. Russian Journal of Hematology and Transfusiology (Gematologiya i transfuziologiya). 2024;69(2):190-199. (In Russ.). https://doi.org/10.35754/0234-5730-2024-69-2-190-199
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.